The two BrCa cell lines were chosen for studying the tumor-specific effects of MB in a p53-WT/estrogen receptor (ER)-positive (MCF7) and a p53 gain-of-function (GoF)/ER-negative (SKBR3) background. The gene discussed is TP53; the disease is neoplasm.